WHO ICTRP trial
Clinical Study on Treatment of Migraine with AnXian-lamotrigine (LTG): an…
ChiCTR-TCC-09000551 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-TCC-09000551 |
|---|---|
| Public title | Clinical Study on Treatment of Migraine with AnXian-lamotrigine (LTG): an open-label controlled study |
| Scientific title | Clinical Study on Treatment of Migraine with AnXian-lamotrigine (LTG): an open-label controlled study |
| Primary sponsor | Department of Neurology of the Brain Hospital Affiliated to Nanjing Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | Post-market |
| Countries | China |
| Conditions | migraine |
| Interventions | Group A:Lamotrigine;Group B:Lamotrigine together with Flunarizine;Group C:Other Anti-Epilepsy Drugs (AEDs) transferred to Lamotrigine;Group D:Other Anti-Epilepsy Drugs (AEDs) transferred to Lamotrigine together with Flunarizine |
| Registration date | Sep 16, 2009 |
| Target size | Group A:50;Group B:50;Group C:50;Group D:50 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: